| 000 | 01155 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514212842.0 | ||
| 264 | 0 | _c20050616 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0304-4602 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKursaklioglu, H | |
| 245 | 0 | 0 |
_aSpironolactone does not prevent restenosis after coronary stenting in humans. _h[electronic resource] |
| 260 |
_bAnnals of the Academy of Medicine, Singapore _cNov 2004 |
||
| 300 |
_a769-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Restenosis _xepidemiology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aIyisoy, A | |
| 700 | 1 | _aAmasyali, B | |
| 700 | 1 | _aCelik, T | |
| 700 | 1 | _aOzturk, C | |
| 700 | 1 | _aKose, S | |
| 700 | 1 | _aIsik, E | |
| 773 | 0 |
_tAnnals of the Academy of Medicine, Singapore _gvol. 33 _gno. 6 _gp. 769-74 |
|
| 999 |
_c15290726 _d15290726 |
||